期刊文献+

抽动障碍儿童血清S100β、CK-BB及GFAP的变化及预后的影响因素分析 被引量:5

Changes of Serum S100β,CK-BB and GFAP levels in Children with Tic Disorder and Analysis of Risk Factors for Poor Prognosis
下载PDF
导出
摘要 目的:探讨抽动障碍儿童血清S100β蛋白、肌酸激酶脑型同工酶(CK-BB)及胶质纤维酸性蛋白(GFAP)水平变化及影响其预后的危险因素。方法:抽动障碍患儿106例根据耶鲁综合抽动严重程度量表(YGTSS)分为中度组83例和重度组23例,选取健康儿童20例为对照组。所有患儿给予硫必利治疗12周。于治疗前、后采血测量血清S100β、CK-BB及GFAP水平,采用多因素logistic回归分析法分析影响患儿预后的危险因素。结果:治疗前,中、重度组的血清S100β、CK-BB及GFAP的浓度均显著高于健康组(均P<0.05),且重度组血清S100β和GFAP均高于中度组(均P<0.05)。治疗后,中、重度组所有指标均低于治疗前(均P<0.05),且中度组血清S100β水平低于重度组(均P<0.05)。根据YGTSS评分,预后良好组共84例,预后不良组22例。2组病情严重程度、病情反复频数及治疗前血清GFAP水平3项指标差异具有统计学意义(均P<0.05),且均是发生抽动障碍患儿预后不佳的危险因素(均P<0.05)。结论:抽动障碍患儿血清中3种脑损伤的参数S100β、CK-BB及GFAP均明显升高,GFAP是该疾病预后不良的危险因素之一。 Objective: To analyze the risk factors for poor prognosis in children with tic disorder(TD) and observe the changes in serum S100β, creatine kinase(CK)- BB and glial fibrillary acidic protein(GFAP) expression. Methods: According to Yale Global Tic Severity Scale(YGTSS), 106 children with TD were divided into moderate group(83 cases) and severe group(23 cases). Twenty healthy children were selected control group. All children with TD received the treatment of Tiapride for 12 weeks. At the first visit after 12-week treatment, the levels of serum S100β, CK-BB and GFAP were detected. Multi-factor logistic regression method was used to analyze the risk factors for poor prognosis. Results: The levels of serum S100β, CK-BB and GFAP in the moderate group and severe group were significantly higher than those in the control group(P〈0.05). Meanwhile, these levels in the severe group were significantly higher than those in the moderate group(P〈0.05). After 12- week treatment, the levels of serum S100β, CK-BB and GFAP in children with TD were significantly lower than those before the treatment(P〈0.05). For the children with TD, severity of TD, the times of reputation and the level of serum GFAP were risk factors for poor prognosis(P〈0.05). Conclusion: The levels of serum S100β, CK-BB and GFAP in children with TD were higher than those in healthy children and GFAP was the risk factor for poor prognosis.
作者 秋艳萍 焦爱萍 张孝兴 席聪 QIU Yan-ping JIAO Ai-ping ZHANG Xiao-xing XI Cong(Baoji Maternity & Child Healthcare Hospital, Shanxi 721000, China Department of Neurology, Shanxi Baoji People's Hospital, Shanxi 721000, China)
出处 《神经损伤与功能重建》 2016年第6期529-532,共4页 Neural Injury and Functional Reconstruction
关键词 抽动障碍 S100Β蛋白 肌酸激酶脑型同工酶-BB 胶质纤维酸性蛋白 危险因素 tic disorder S100β protein creatine kinase-BB glial fibrillary acidic protein risk factors
  • 相关文献

参考文献4

二级参考文献27

  • 1尚游,袁世荧,姚尚龙.心搏骤停后脑损伤预后评价的新指标—血清S100_β蛋白[J].中华急诊医学杂志,2004,13(5):357-358. 被引量:7
  • 2杨靖.血清CK、LDH、GOT测定对判断颅脑损伤病情的临床价值[J].中国医师杂志,2004,6(10):1427-1428. 被引量:13
  • 3吴小娅,杨瑞疆.动态监测血清CPK、LDH、AST活性对颅脑损伤程度及预后评估的价值[J].浙江医学,2006,28(8):683-684. 被引量:3
  • 4中华医学会精神科分会.中国精神障碍分类与诊断标准第3版[M].济南:山东科学技术出版社,2001:9-168.
  • 5Kurlan R. Handbook of Tourette's syndrome and related tic and behavioral disorders [ M ]. 2^nd ed. New York : Maecel Dekker , 2005 : 155 - 171.
  • 6World Health Organization. The ICD - 10 classification of mental and behavioral disorders: Clinical descriptions and diagnostic guidelines [OL]. www. who. int/classifications/icd/en/bluebook.pdf.
  • 7Dooley JM. Tic disorders in childhood[ J ]. Semin Pediatr Neuro1,2006, 13(4) :231 -242.
  • 8Parraga HC, Harris KM, Parraga KL, et al. An overview of the treatment of Tourette's disorder and tics [ J ]. J Child Adolesc Psychopharmacol, 2010,20(4) :249 -262.
  • 9Lyon GJ, Samar S ,Jummani R ,et al. Aripiprazole in children and adolescents with Tourette's disorder:An open -label safety and tolerability study [ J ]. J Child Adolesc Psychopharmacol, 2009,19 ( 6 ) : 623 - 633.
  • 10Franklin SA, Michael RW, Douglas WW. Behavioral interventions for tie disorders [ J ]. Psyehiatr Clin North Am, 2010,33 ( 3 ) : 641 - 655.

共引文献34

同被引文献49

引证文献5

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部